ResMed Inc (BSP:R1MD34)
R$ 381 9.84 (2.65%) Market Cap: 223.72 Bil Enterprise Value: 226.25 Bil PE Ratio: 32.98 PB Ratio: 7.04 GF Score: 86/100

Q2 2022 Resmed Inc Earnings Call Transcript

Jan 27, 2022 / 09:30PM GMT
Release Date Price: R$347.2
Operator

Hello, and welcome to the ResMed Second Quarter Fiscal Year 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to Amy Wakeham, Vice President, Investor Relations and Corporate Communications. Please go ahead, Amy.

Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

Great. Thanks, Kevin, and hi, everyone. Welcome to ResMed's Second Quarter Fiscal Year 2022 Earnings Conference Call. We thank you for joining us. This call is being webcast live and the replay will be available on the Investor Relations section of our corporate website later today, along with a copy of the earnings press release and presentation, which are both available now.

With me on the call today are Chief Executive Officer, Mick Farrell; and Chief Financial Officer, Brett Sandercock. During the Q&A portion of our call, Mick and Brett will be joined by Rob Douglas, our President and Chief Operating Officer; Jim Hollingshead, our President, Sleep and Respiratory

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot